The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.
The Genome Project–write leaders propose the development of virus-resistant cells, according to Science.
ExxonMobil and Synthetic Genomics are moving forward with their exploration of algae-based biofuels, the San Diego Union-Tribune reports.
The computational tools will be designed to screen DNA sequences to detect biological threats that may arise from synthetic microbial manipulation.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
The Genome Project-Write researchers are meeting again, but ScienceInsider notes that the effort is lacking funds.
The company, which is collaborating with Myeloma Crowd, will use the newly-licensed minicircle DNA technology to develop therapies for multiple myeloma.
In Science this week: a suite of studies from the Synthetic Yeast genome Project.
Cancer researcher Alan Rabson has died at 92, the New York Times reports.
As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.
In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.
The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.